American Journal of Epidemiology Advance Access published online on January 27, 2006
American Journal of Epidemiology, doi:10.1093/aje/kwj069
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 From the Copenhagen Trial Unit, Center for Clinical Intervention Research, Cochrane Hepato-Biliary Group, Copenhagen, Denmark
* To whom correspondence should be addressed. Research on bias in clinical trials may help identify some of the reasons why investigators sometimes reach the wrong conclusions about intervention effects. Several quality components for the assessment of bias control have been suggested, but although they seem intrinsically valid, empirical evidence is needed to evaluate their effects on the extent and direction of bias. This narrative review summarizes the findings of methodological studies on the influence of bias in clinical trials. A number of methodological studies suggest that lack of adequate randomization in published trial reports may be associated with more positive estimates of intervention effects. The influence of double-blinding and follow-up is less clear. Several studies have found a significant association between funding sources and pro-industry conclusions. However, the methodological studies also show that bias is difficult to detect and appraise. The extent of bias in individual trials is unpredictable. A-priori exclusion of trials with certain characteristics is not recommended. Appraising bias control in individual trials is necessary to avoid making incorrect conclusions about intervention effects.
Received January 26, 2005
Accepted October 27, 2005
REVIEW
Bias in Clinical Intervention Research
Lise Lotte Gluud 1 *
Lise Lotte Gluud, E-mail: lgluud{at}ctu.rh.dk
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Salanti, J. P. Higgins, A. Ades, and J. P. Ioannidis Evaluation of networks of randomized trials Statistical Methods in Medical Research, June 1, 2008; 17(3): 279 - 301. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Abrahamyan, S. R. Johnson, J. Beyene, P. S. Shah, and B. M. Feldman Quality of randomized clinical trials in juvenile idiopathic arthritis Rheumatology, May 1, 2008; 47(5): 640 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Feagan, W. J. Sandborn, U. Mittmann, S. Bar-Meir, G. D'Haens, M. Bradette, A. Cohen, C. Dallaire, T. P. Ponich, J. W. D. McDonald, et al. Omega-3 Free Fatty Acids for the Maintenance of Remission in Crohn Disease: The EPIC Randomized Controlled Trials JAMA, April 9, 2008; 299(14): 1690 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wood, M. Egger, L. L. Gluud, K. F Schulz, P. Juni, D. G Altman, C. Gluud, R. M Martin, A. J G Wood, and J. A C Sterne Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study BMJ, March 15, 2008; 336(7644): 601 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Boutron, D. Moher, D. G. Altman, K. F. Schulz, P. Ravaud, and for the CONSORT Group Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration Ann Intern Med, February 19, 2008; 148(4): 295 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Marmor, I. Belitskaya-Levy, and A. A. Arslan RE: LETTER TO THE EDITOR ON "BIAS IN CLINICAL INTERVENTION RESEARCH" Am. J. Epidemiol., February 15, 2008; 167(4): 500 - 501. [Full Text] [PDF]
|
|
|
|
|
|
A. Afshari, J. Wetterslev, J. Brok, and A. Moller Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis BMJ, December 15, 2007; 335(7632): 1248 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chan MD MPH A clinical trial gone awry: the Chocolate Happiness Undergoing More Pleasantness (CHUMP) study Can. Med. Assoc. J., December 4, 2007; 177(12): 1539 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Gluud, G. Bjelakovic, D. Nikolova, R. G. Simonetti, and C. Gluud Antioxidant Supplements and Mortality Reply JAMA, July 25, 2007; 298(4): 402 - 403. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Boutron, P. Ravaud, and R. Nizard The design and assessment of prospective randomised, controlled trials in orthopaedic surgery J Bone Joint Surg Br, July 1, 2007; 89-B(7): 858 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hemila RE: "BIAS IN CLINICAL INTERVENTION RESEARCH" Am. J. Epidemiol., May 15, 2007; 165(10): 1219 - 1219. [Full Text] [PDF]
|
|
|
|
|
|
L. L. Gluud THE AUTHOR REPLIES Am. J. Epidemiol., May 15, 2007; 165(10): 1219 - 1220. [Full Text] [PDF]
|
|
|
|
|
|
G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-analysis JAMA, February 28, 2007; 297(8): 842 - 857. [Abstract] [Full Text] [PDF]
|
|